Transgenic mice expressing Alzheimer amyloid precursor proteins

Experimental Gerontology

Volumn 33, Issue 7-8, 1998, Pages 883-889

  Hsiao, Karen ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Alzheimer's disease; Amyloid precursor protein; Modifying genes; Transgenic mice

Indexed keywords

PROTEIN PRECURSOR; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GLIOSIS; GLUCOSE UTILIZATION; HISTOPATHOLOGY; IMMUNOREACTIVITY; LEARNING; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; TRANSGENIC MOUSE;

AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; HUMANS; MICE; MICE, TRANSGENIC; PHENOTYPE;

EID: 0032417251     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0531-5565(98)00045-X     Document Type: Conference Paper

References (30)

1. Bales K.R., Verina T., Dodel R.C., Du Y., Alstiel L., Bender M., Hyslop P., Johnston E.M., Little S.P., Cummins D.J., Piccardo P., Ghetti B., Paul S.M. Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition. Nat. Genet. 17:1997;263-264.
2. Borchelt D.R., Ratovitski T., Van Lare J., Lee M.K., Gonzales V., Jenkins N.A., Copeland N.G., Price D.L., Sisodia S.S. Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron. 19:1997;939-945.
3. Cai X.-D., Golde T.E., Younkin S.G. Release of excess amyloid β protein from a mutant amyloid β protein precursor. Science. 259:1993;514-516.
4. Carlson G.A., Borchelt D.R., Dake A., Turner S., Danielson V., Coffin J.D., Eckman C., Meiners J., Nilsen S.P., Younkin S.G., Hsiao K.K. Genetic modification of the phenotypes produced by amyloid precursor protein overexpression in transgenic mice. Hum. Mol. Genet. 6:1997;1951-1959.
5. Duff K., Eckman C., Zehr C., Yu X., Prada C.M., Perez-Tur J., Hutton M., Bull L., Harigaya Y., Yager D., Morgan D., Gordon M.N., Holcomb L., Refolo L., Zenk B., Hardy J., Younkin S. Increased amyloid-beta42(43) in brains of mice expressing presenilin 1. Nature. 383:1996;710-713.
6. Frautschy S.A., Yang F., Irizarry M., Hyman B., Saido T.C., Hsiao K., Cole G.M. The microglial response to amyloid plaques in APPsw transgenic mice. Am. J. Pathol. 152:1998;307-317.
7. Games D., Adams D., Alessandrini R., Barbour R., Berthelotte P., Blackwell C., Carr T., Clemens J., Donaldson T., Gillespie F., Guido T., Hagoplan S., Johnson-Wood K., Khan K., Lee M., Leibowitz P., Lieberburg I., Little S., Masliah E., Mcconlogue L., Montoya-Zavaia M., Mucke L., Paganini L., Penalman E., Power M., Schenk D., Peubert P., Snyder B., Soriano F., Tan H., Vitale J., Wadsworth S., Wolozin B., Zhao J. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature. 373:1995;523-527.
8. Goelz M.F., Mahler J., Harry J., Myers P., Clark J., Thigpen J.E., Forsythe D.B. Neuropathologic findings associated with seizures in FVB mice. Lab. Anim. Sci. 48:1998;34-37.
9. Higgins L.S., Rodems J.M., Catalano R., Quon D., Cordell B. Early Alzheimer disease-like pathology increases in frequency with age in mice transgenic for beta-APP751. Proc. Natl. Acad. Sci. USA. 92:1995;4402-4406.
10. Holcomb L., Gordon M.N., Mcgowan E., Yin X., Benkovic S., Jantzen P., Wright K., Saad I., Mueller R., Morgan D., Sanders S., Zehr C., O'Campo K., Hardy J., Prada C.-M., Eckman C., Younkin S., Hsiao K., Duff K. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat. Med. 4:1998;97-100.
11. Hsiao K., Borchelt D., Olson K., Johannsdottir R., Kitt C., Yunis W., Xu S., Eckman C., Younkin S., Price D., Iadecola C., Clark H.B., Carlson G. Age-related disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins. Neuron. 15:1995;1-16.
12. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., Cole G. Correlative memory deficits, Aβ elevation and amyloid plaques in transgenic mice. Science. 274:1996;99-102.
13. Hsiao, KK. , Understanding the biology and molecular pathogenesis of Alzheimer's disease in transgenic mice expressing amyloid precursor proteins. In Molecular Mechanisms of Dementia, Wasco, W and Tanzi, R.E. (editors), pp. 39-43, Humana Press Inc., Totowa, NJ, 1997.
14. Sw transgenic mice develop age-related Aβ deposits and neurophil abnormalities, but no neuronal loss in CA1. J. Neuropathol. Exp. Neurol. 56:1997;965-973.
15. Johnson-Wood K., Lee M., Motter R., Hu K., Gordon G., Barbour R., Khan K., Bordon M., Tan H., Games D., Lieberburg I., Schenk D., Seubert P., Mcconlogue L. Amyloid precursor processing and A-beta 42 deposition in a transgenic mouse model of Alzheimer disease. Proc. Natl. Acad. Sci. USA. 94:1997;1550-1555.
16. Kammesheidt A., Boyce F.M., Spanoyannis A.F., Cummings B.J., Ortegon M., Cotman C.W., Vaught J.L., Neve R.L. Amyloid deposition and neuronal pathology in transgenic mice expressing the carboxylterminal fragment of the Alzheimer amyloid precursor in the brain. Proc. Natl. Acad. Sci. USA. 89:1992;10857-10861.
17. Klunk, W., Hamilton, R.L., Styren S.D., Styren G., Debnath, M.L., Mathis, C.A., Mahmood, K., and Hsiao, K.K. , Staining of AD and Tg2576 mouse brain with X-34, a highly fluorescent derivative of chrysamine G and a potential in vivo probe for β-sheet fibrils. Soc. Neurosci. Abstr. 23, 1638, 1997.
18. Laferla F.M., Tinkle B.T., Bieberisch C.J., Haudenschild C.C., Jay G. The Alzheimer's Aβ peptide induces neurodegeneration and apoptotic cell death in transgenic mice. Nat. Genet. 9:1995;21-30.
19. Moechars D., Lorent K., De Strooper B., Dewachter I., Van Leuven F. Expression in brain of amyloid precursor protein mutated in the α-secretase site causes disturbed behavior, neuronal degeneration and premature death in transgenic mice. EMBO J. 15:1996;1265-1274.
20. Moran P.M., Higgins L.S., Cordell B., Moser P.C. Age-related learning deficits in transgenic mice expressing the 751-amino acid isoform of human β-amyloid precursor protein. Proc. Natl. Acad. Sci. USA. 92:1995;5341-5345.
21. Nalbantoglu, J., Tirado-Santiago, G., LAHSAÏNI, A., Poirier, J., Goncalves, O., Verge, G., Momoli, F., Welner, S.A., Massicotte, G., , JULIEN, J.-P., and SHAPIRO, M.L. Impaired learning and LTP in mice expressing the carboxy terminus of the Alzheimer amyloid precursor protein. Nature 387, 500-505, 1997.
22. Oster-Granite M.L., Mcphie D.L., Greenan J., Neve R.L. Age-dependent neuronal and synaptic degeneration in mice transgenic for the C-terminus of the amyloid precursor protein. J. Neurosci. 16:1996;6732-6741.
23. Pappolla, M.A., , CHYAN, Y.-J., BOZNER, P., OMAR, R.A., HSIAO, K., PERRY, G., and SMITH, M. Evidence of oxidative stress and in vivo neurotoxicity of beta amyloid in a transgenic mouse model of Alzheimer's disease. Am. J. Pathol.152, 871-877, 1998.
24. Quon D., Wang Y., Catalano R., Scardina J.M., Murakami K., Cordell B. Formation of β-amyloid protein deposits in brains of transgenic mice. Nature. 352:1991;239-241.
25. Smith M.A., Hirai K., Hsiao K., Pappolla M.A., Harris P.L.R., Perry G. Amyloid-β deposition in transgenic mice initiates oxidative stress analogous to Alzheimer disease. J. Neurochem. 70:1998;2212-2215.
26. Sturchler-Pierrat, C., Abramowski, D., Duke, M., , WIEDERHOLD, K.-H., MISTL, C., ROTHACHER, S., LEDERMANN, B., BÜRKI, K., FREY, P., PAGANETTI, P.A., WARIDEL, C., CALHOUN, M.E., JUCKER, M., PROBST, A., STAUFENBIEL, M., and SOMMER, B. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc. Natl. Acad. Sci. USA94, 13287-13292, 1997.
27. Suzuki, N., Cheung, T.T., Cai, X.D., Okada, A., Otvos, JR., , L., ECKMAN, C., GOLDE, T.E., and YOUNGKIN, S.G. An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. Science264, 1335-1340, 1994.
28. Wyss-Coray T., Masliah E., Mallory M., McConlogue L., Johnson-Wood K., Lin C., Mucke L. Amyloidogenic role of cytokine TGF-β1 in transgenic mice and Alzheimer's disease. Nature. 389:1997;603-606.
29. Zhang F., Hsiao K.K., Mucke L., Iadecola C. Worsening of focal cerebral ischemic damage in transgenic mice overexpressing amyloid precursor protein. Soc. Neurosci. Abstr. 21:1995;994.
30. Zhang F., Eckman C., Younkin S., Hsiao K., Iadecola C. Increased susceptibility to ischemic brain damage in transgenic mice overexpressing the amyloid precursor protein. J. Neurosci. 17:1997;7655-7661.